Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Gene Rank description Network Comparison Type Value Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 501 to 550 of 6456 in total 
Value Type: Measured
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
251\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
breast cancer antiestrogen resistance 3. [source:refseq;acc:nm\_003567]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4579.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5940.64\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1361.3\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosine-protein kinase hck (ec 2.7.1.112) (p59-hck/p60-hck) (hemopoietic cell kinase). [source:swissprot;acc:p08631]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6417.18\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
7859.6\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.22477\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
252\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
crk-like protein. [source:swissprot;acc:p46109]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
glycogen [starch] synthase, muscle (ec 2.4.1.11). [source:swissprot;acc:p13807]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
9648.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10994.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1346.63\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
253\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
endo-beta-n-acetylglucosaminidase. [source:refseq;acc:nm\_022759]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
9642.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10986.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1344.18\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase abl1 (ec 2.7.1.112) (p150) (c-abl). [source:swissprot;acc:p00519]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6417.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7859.59\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22477\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
254\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycogen [starch] synthase, liver (ec 2.4.1.11). [source:swissprot;acc:p54840]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9634.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10976.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1341.22\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase fyn (ec 2.7.1.112) (p59-fyn) (syn) (slk). [source:swissprot;acc:p06241]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6417.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7859.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22477\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
255\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
mad protein (max dimerizer). [source:swissprot;acc:q05195]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4455.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5774.03\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1318.08\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase fgr (ec 2.7.1.112) (p55-fgr) (c-fgr). [source:swissprot;acc:p09769]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6417.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7859.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22477\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
256\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
grb2-related adaptor protein 2 (gads protein) (growth factor receptor binding protein) (grblg) (grf40 adaptor protein) (grf-40) (grb-2-like protein) (grb2l) (grbx) (p38) (hematopoietic cell-associated adaptor protein grpl) (adapter protein grid) (sh3-sh2-sh3 adaptor mona). [source:swissprot;acc:o75791]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6417.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7859.51\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22476\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
max interacting protein 1 (mxi1 protein). [source:swissprot;acc:p50539]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4456.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5773.77\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1317.1\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
257\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ccaat displacement protein (cdp) (cut-like 1). [source:swissprot;acc:p39880]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6417.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7858.12\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22452\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
max-interacting transcriptional repressor mad4 (max-associated protein 4) (max dimerization protein 4). [source:swissprot;acc:q14582]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4456.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5773.67\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1316.74\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
258\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein cux-2 (cut-like 2) (fragment). [source:swissprot;acc:o14529]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6417.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7857.93\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22449\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
max dimerization protein 3; likely ortholog of mouse max dimerization protein 3. [source:refseq;acc:nm\_031300]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4457.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5773.63\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1316.57\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
259\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
neural wiskott-aldrich syndrome protein (n-wasp). [source:swissprot;acc:o00401]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6417.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7852.52\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22355\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein sm d3 (snrnp core protein d3) (sm-d3). [source:swissprot;acc:p43331]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4569.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5885.79\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1316.31\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
260\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytidine triphosphate synthase ii; ctp synthetase type 2; utp-ammonia ligase; ctp synthetase isoform; cytidine 5'-triphosphate synthetase 2. [source:refseq;acc:nm\_019857]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
12515.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11221.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1294.3\vspace{3pt}}\\\cline{2-6}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
signal recognition particle 9 kda protein (srp9). [source:swissprot;acc:p49458]\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4244.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5193.42\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22343\vspace{3pt}}\\\cline{1-1}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
261\vspace{3pt}}}&&&\parbox{\wcD}{\vspace{3pt}\noindent
4247.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5192.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.22255\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
source of immunodominant mhc-associated peptides; homolog of yeast stt3 gene. [source:refseq;acc:nm\_178862]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4571.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5864.86\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1292.97\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
262\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cleavage and polyadenylation specific factor 4, 30kd subunit; cleavage-polyadenylation specificity factor, 30kd; no arches-like (zebrafish) zinc finger protein; cleavage-polyadenylation specificity factor. [source:refseq;acc:nm\_006693]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
24896.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
20431.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21852\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
oligosaccharyl transferase stt3 subunit homolog (b5) (integral membrane protein 1) (tmc). [source:swissprot;acc:p46977]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4571.89\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
5864.86\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1292.97\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
263\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kda subunit precursor (ec 2.4.1.119) (oligosaccharyl transferase 48 kda subunit) (ddost 48 kda subunit). [source:swissprot;acc:p39656]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
trs85 homolog. [source:swissprot;acc:q9y2l5]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
24896.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
20431.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21852\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
264\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cop9 constitutive photomorphogenic homolog subunit 3; cop9 complex subunit 3; jab1-containing signalosome subunit 3. [source:refseq;acc:nm\_003653]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4987.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4094.57\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.2181\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ctp synthase (ec 6.3.4.2) (utp--ammonia ligase) (ctp synthetase). [source:swissprot;acc:p17812]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
12503.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11212\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1291.3\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
265\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor 3b subunit 1 (spliceosome associated protein 155) (sap 155) (sf3b155) (pre-mrna splicing factor sf3b 155 kda subunit). [source:swissprot;acc:o75533]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4638.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5923.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1285.3\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
wd-repeat protein wdc146. [source:swissprot;acc:q9c0j8]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
24806.9\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
20369.9\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.21782\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
266\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cleavage and polyadenylation specificity factor, 160 kda subunit (cpsf 160 kda subunit). [source:swissprot;acc:q10570]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 4 (anion exchanger), member 1, adaptor protein; kidney anion exchanger adaptor protein; kanadaptin; lung cancer oncogene 3. [source:refseq;acc:nm\_018158]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
11222.2\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
9948.93\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1273.27\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
267\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclin-dependent kinases regulatory subunit 2 (cks-2). [source:swissprot;acc:p33552]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ral guanine nucleotide dissociation stimulator (ralgef) (ralgds). [source:swissprot;acc:q12967]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14021.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11523\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21682\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
268\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
catenin (cadherin-associated protein), alpha-like 1; alpha-catulin. [source:refseq;acc:nm\_003798]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11222.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9948.93\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1273.27\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cleavage and polyadenylation specificity factor, 100 kda subunit (cpsf 100 kda subunit) (fragment). [source:swissprot;acc:q9p2i0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
24473.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
20127.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21593\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
269\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
crk-associated substrate (p130cas) (breast cancer anti-estrogen resistance 1 protein). [source:swissprot;acc:p56945]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4808.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6074.21\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1265.42\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
u6 snrna-associated sm-like protein lsm8. [source:swissprot;acc:o95777]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4590.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5575.52\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21466\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
270\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
fip1-like 1; rearranged in hypereosinophilia. [source:refseq;acc:nm\_030917]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
23640.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
19479.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21358\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
t-complex protein 1, delta subunit (tcp-1-delta) (cct-delta) (stimulator of tar rna binding). [source:swissprot;acc:p50991]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4810.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6075.04\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1264.82\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
271\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromatin accessibility complex protein 1 (chrac-1) (chrac-15) (huchrac15) (dna polymerase epsilon subunit p15). [source:swissprot;acc:q9nrg0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2554.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3093.78\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21092\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
enhancer of filamentation 1 (hef1) (crk-associated substrate-related protein) (cas-l) (casl) (pp105) (neural precursor cell expressed developmentally down-regulated 9). [source:swissprot;acc:q14511]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4812.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6076.09\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1264.08\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
272\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone acetyltransferase type b catalytic subunit (ec 2.3.1.48). [source:swissprot;acc:o14929]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3858.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4669.27\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21012\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase subunit b17.2 (ec 1.6.5.3) (ec 1.6.99.3) (complex i-b17.2) (ci-b17.2) (cib17.2) (13 kda differentiation-associated protein). [source:swissprot;acc:q9ui09]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1991.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3221.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1230.35\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
273\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 5 (eif-5). [source:swissprot;acc:p55010]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3199.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3870.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20985\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ribosomal protein s6 kinase, 52kda, polypeptide 1; ribosomal protein s6 kinase, 52kd, polypeptide 1. [source:refseq;acc:nm\_012424]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5181.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6410.58\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1229.38\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
274\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromosome 3p21.1 gene sequence. [source:refseq;acc:nm\_013286]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3119.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2579.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20953\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ribosomal protein s6 kinase-like 1. [source:refseq;acc:nm\_031464]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5181.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6410.58\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1229.38\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
275\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial precursor (ec 3.6.1.23) (dutpase) (dutp pyrophosphatase). [source:swissprot;acc:p33316]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
10264.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9043.51\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1221.39\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
regulator of g-protein signaling 19 (rgs19) (g-alpha interacting protein) (gaip protein). [source:swissprot;acc:p49795]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3119.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2579.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20953\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/